Keith Flanagan served as senior health counsel on the U.S. Senate’s Health, Education, Labor, and Pensions (HELP) Committee; founded the offices of new and generic drug policy in the FDA’s Center for Drug Evaluation and Research; and now consults for patient groups, biopharmaceutical innovators, and investors.